Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K072619
    Manufacturer
    Date Cleared
    2007-11-21

    (65 days)

    Product Code
    Regulation Number
    888.3565
    Reference & Predicate Devices
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    General Indications for the NexGen Complete Knee Solution Femoral Components:

    • This device is indicated for patients with severe knee pain and disability due to:
    • Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.
    • Collagen disorders, and/or avascular necrosis of the femoral condyle.
    • Post-traumatic loss of joint configuration. particularly when there is patellofemoral erosion, dysfunction or prior patellectomy
    • Moderate valgus, varus, or flexion deformities.
    • The salvage of previously failed surgical attempts or for a knee in which satisfactory stability in flexion cannot be obtained at the time of surgery.

    Porous coated femoral components may be used cemented or uncemented (biological fixation).

    Specific Indications for the LPS-Flex Porous Femoral Components:

    • · LPS- Flex porous coated femoral and tibial baseplate components may be used cemented or uncemented (biological fixation).
    • · Specific uses with the LPS-Flex femorals:

    Intended Use:

    • Provides increased flexion capability for patients who have both the flexibility and desire to increase their flexion range.
    • The LPS-Flex femoral, when used with the LPS-Flex articular surfaces, is designed for use with both cruciate ligaments excised and when load bearing range of motion (ROM) is expected to be less than or equal to 155 degrees.

    Specific Indications for the NexGen Knee GSF Knee Porous Femoral Components:

    • · CR-Flex GSF and LPS-Flex GSF porous coated femoral components may be used cemented or uncemented (biological fixation).
    • · Specific uses with CR-Flex GSF or LPS-Flex GSF femorals:
    • Provides increased flexion capability for patients who have both the flexibility and desire to increase their flexion range.
    • The CR-Flex GSF femoral, when used with 90prefix NexGen CR articular surfaces, 00-prefix 10, 12 or 14mm or 90-prefix 17 or 20mm Prolong" Highly Crosslinked Polyethylene CR articular surfaces, or with Gender Solutions Natural-Knee® Flex Congruent articular surfaces, is designed for use with a functional posterior cruciate ligament and when load bearing range of motion (ROM) is expected to be less than or equal to 155 degrees.
    • The LPS-Flex GSF femoral, when used with LPS-Flex articular surfaces, is designed for use with both cruciate ligaments excised and when load bearing ROM is expected to be less than or equal to 155 degrees.
    Device Description

    The LPS-Flex Fixed-bearing Knee is a semi-constrained, condylar system for use without the cruciate ligaments when additional stability is required to prevent anterior subluxation of the femur relative to the tibia in flexion. The LPS-Flex Porous femoral component is designed to have a maximum active, load bearing range of motion of 155 degrees. It contains a fiber metal pad to allow for cementless use.

    The GSF Porous femoral components include both LPS-Flex GSF and CR-Flex GSF versions and are part of the Zimmer Flex-series of semi-constrained, non-linked, condylar knee prostheses that are designed to have a maximum active, load bearing range of motion of 155 degrees. The GSF designation indicates that the femoral component is designed to better match distal femoral anatomic features more typical of female patients. They contain fiber metal pads to allow for cementless use.

    AI/ML Overview

    The provided document is a 510(k) summary for a medical device (NexGen® Complete Knee Solution LPS-Flex Porous Femoral Component, NexGen Knee Gender Solutions™ Female (GSF) Porous Femoral Components). It describes the device, its indications for use, and a comparison to predicate devices, but it does not contain information related to software or AI-driven diagnostic devices, nor does it present specific acceptance criteria or a study proving that such criteria are met.

    Therefore, I cannot extract the requested information regarding acceptance criteria, reported device performance, sample sizes for test/training sets, ground truth establishment, expert adjudication, or MRMC studies for an AI device from this document. The document explicitly states:

    "Clinical data and conclusions were not needed for these devices."

    And the performance data section states:

    "Mechanical testing of the proposed devices indicate that they are substantially equivalent to the predicate devices."

    This indicates that the clearance for these orthopedic implants was based on substantial equivalence to existing predicate devices, primarily through non-clinical mechanical testing, rather than through clinical studies with acceptance criteria as would be typical for a diagnostic or AI-driven device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1